Heritage Oak Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,735
Closed -$212K – 96
2025
Q4
$212K Buy
+1,735
New +$199K 0.08% 75

Other funds holding XBI

Heritage Oak Wealth Advisors's XBI Position: Q1 2026 in Review

Heritage Oak Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 1,735 shares — an estimated $212K sold.

Heritage Oak Wealth Advisors first reported a position in XBI in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Heritage Oak Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • Heritage Oak Wealth Advisors sold 1,735 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $212K.
  • Heritage Oak Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and held it in 1 quarter.
  • Heritage Oak Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $212K in Q4 2025.
  • 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Heritage Oak Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.